Expanded Safety and Immunogenicity of a Bivalent, Oral, Attenuated Cholera Vaccine, CVD 103-HgR Plus CVD 111, in United States Military Personnel Stationed in Panama

To provide optimum protection against classical and El Tor biotypes of Vibrio cholerae O1, a single-dose, oral cholera vaccine was developed by combining two live, attenuated vaccine strains, CVD 103-HgR (classical, Inaba) and CVD 111 (El Tor, Ogawa). The vaccines were formulated in a double-chamber...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Taylor, David N., Sanchez, José L., Castro, José M., Lebron, Carlos, Parrado, Carlos M., Johnson, David E., Tacket, Carol O., Losonsky, Genevieve A., Wasserman, Steven S., Levine, Myron M., Cryz, Stanley J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Microbial Immunity and Vaccines
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC96565/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10085055/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.67.4.2030-2034.1999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!